Commercialising a novel discovery in the field of medicine requires a critical path analysis and knowledge of how to achieve specific studies on this critical path.
Discovery 2 Medicine (D2M) provides industrial and academic expertise through an expert review panel and gives advice and mechanisms to take projects forward. Discovery 2 Medicine, having identified a real need for this kind of service, has assisted a significant number of projects and companies.
The Board acts as a team and its breadth of experience means that it is thus capable of contributing to each individual problem identified by its customers. This makes Discovery 2 Medicine’s offering unique.
17 May 2011
Bionow Ltd is now open for business
6 May 2011
£20m management training fund will help small businesses grow
18 April 2011
Low Carbon and Environment Competition-Heat 3 Now Open
Thermo Fisher Scientific and D2M Collaboration
D2M provides independent review and advice on grant applications
Imagen Biotech NWDA Innovation Voucher
